Health
COVID-19-related disruptions to cervical cancer screening could increase risk sevenfold, UK case study finds – News-Medical.Net
A new study reveals inequalities in the delay in screening for cervical cancer, and recommends that the screening capacity be increased in addition to giving a…
The coronavirus 2019 (COVID-19) pandemic has interrupted social and economic activity and has led to a huge wave of sickness and death. However, there are other healthcare costs as well, one of which is the interruption of scheduled screening for diseases that can be cured if diagnosed early; one such disease is cervical cancer.
A new study reveals inequalities in the delay in screening for this cancer, and recommends that the screening capacity be increased in addition to giving a higher priority…
-
Business18 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business14 hours agoDicker Data rides the AI trend to double digit growth
-
Business22 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News15 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference